Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

NCT01795027 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

724

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1 plus oxaliplatin
DRUG: S-1 single

Sponsor

Sun Yat-sen University